: Restoring miR-7 levels through "mimics" is being explored as an adjuvant therapy to sensitize cancer cells to chemotherapy and overcome multidrug resistance.
MicroRNA-7 is a highly conserved, non-coding RNA molecule approximately 22 nucleotides long. In humans, the mature miR-7 sequence is generated from three distinct genomic loci: (Chromosome 9), MIR7-2 (Chromosome 15), and MIR7-3 (Chromosome 19). It is primarily recognized as a "network stabilizer" that maintains cellular homeostasis under environmental stress. Biological Functions and Regulation
miR-7 is preferentially expressed in neuroendocrine tissues, specifically the and pancreas . Mirna.7z
: It generally acts as a tumor suppressor . Its downregulation is linked to increased proliferation and metastasis in glioblastoma, lung, breast, and colorectal cancers by failing to inhibit oncogenic pathways like EGFR/PI3K/Akt .
: Its levels are controlled post-transcriptionally by "sponges" like circular RNA ciRS-7 (also known as CDR1as), which contains over 70 binding sites for miR-7 and can effectively quench its activity. Role in Pathophysiology : Restoring miR-7 levels through "mimics" is being
: Its expression levels in peripheral blood or tissues can serve as a biomarker for cancer prognosis or disease staging.
: Recent studies highlight its role in regulating immune responses, including T-cell activation and neuroinflammation. Clinical Potential Due to its broad regulatory reach, miR-7 is a target for: It is primarily recognized as a "network stabilizer"
The dysregulation of miR-7 is a hallmark of several major pathologies: